Literature DB >> 3018133

Detection of human papillomavirus type 16 DNA and evidence for integration into the cell DNA in cervical dysplasia.

H Shirasawa, Y Tomita, K Kubota, T Kasai, S Sekiya, H Takamizawa, B Simizu.   

Abstract

The presence of human papillomavirus (HPV) type 16 DNA in biopsies from precancerous lesions and from early lesions of human cervical cancer, and the integration of virus DNA into host cell DNA were analysed by dot blot and Southern blot hybridizations. HPV 16 DNA was detected in 23% of mild dysplasias, 32% of moderate dysplasias, 55% of severe dysplasias and 62% of carcinomas in situ by dot blot hybridization. Digestion of the DNA with restriction enzymes PstI and BamHI followed by Southern blot analysis revealed the presence of some typical restriction fragments of HPV 16 DNA in most virus-positive samples. In addition, we detected submolar fragments which might represent virus-cell junction sequences in 86% of dysplasias, suggesting that the integration of HPV 16 DNA could occur in the precancerous stage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018133     DOI: 10.1099/0022-1317-67-9-2011

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas.

Authors:  H Shirasawa; Y Tomita; K Kubota; T Kasai; S Sekiya; H Takamizawa; B Simizu
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

3.  Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.

Authors:  K Cooper; C S Herrington; J E Stickland; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

4.  Differential effects of human papillomavirus type 6, 16, and 18 DNAs on immortalization and transformation of human cervical epithelial cells.

Authors:  G Pecoraro; D Morgan; V Defendi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique.

Authors:  Panu Peitsaro; Bo Johansson; Stina Syrjänen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Interleukin-6 (IL-6) production in carcinoma of the cervix.

Authors:  H Takano; K Harigaya; G Ishii; Y Sugaya; S Soeta; T Nunoyama; H Shirasawa; K Shimizu; H Tokita; B Simizu; A Mikata; S Sekiya
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

7.  Expression of human papillomavirus types 6b and 16 L1 open reading frames in Escherichia coli: detection of a 56,000-dalton polypeptide containing genus-specific (common) antigens.

Authors:  Y Tomita; H Shirasawa; B Simizu
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis.

Authors:  W Z Mehal; Y M Lo; C S Herrington; M F Evans; M C Papadopoulos; K Odunis; T S Ganesan; J O McGee; J I Bell; K A Fleming
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

9.  Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Bauknecht; D Bartsch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology.

Authors:  S-M A Kulmala; S M Syrjänen; U B Gyllensten; I P Shabalova; N Petrovichev; P Tosi; K J Syrjänen; B C Johansson
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.